NIMODIPINE Drug Patent Profile
✉ Email this page to a colleague
When do Nimodipine patents expire, and when can generic versions of Nimodipine launch?
Nimodipine is a drug marketed by Bionpharma, Heritage Pharms, Sofgen Pharms, Sun Pharm Inds Inc, and Thepharmanetwork Llc. and is included in five NDAs.
The generic ingredient in NIMODIPINE is nimodipine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nimodipine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nimodipine
A generic version of NIMODIPINE was approved as nimodipine by HERITAGE PHARMS on May 2nd, 2007.
Summary for NIMODIPINE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Clinical Trials: | 44 |
| Patent Applications: | 4,111 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NIMODIPINE |
| DailyMed Link: | NIMODIPINE at DailyMed |
Recent Clinical Trials for NIMODIPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Daqing people's Hospital | Phase 3 |
| Hengshui People's Hospital | Phase 3 |
| Nanyang nanshai hospital | Phase 3 |
Pharmacology for NIMODIPINE
| Drug Class | Dihydropyridine Calcium Channel Blocker |
| Mechanism of Action | Calcium Channel Antagonists |
Medical Subject Heading (MeSH) Categories for NIMODIPINE
Anatomical Therapeutic Chemical (ATC) Classes for NIMODIPINE
Paragraph IV (Patent) Challenges for NIMODIPINE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| NYMALIZE | Oral Solution | nimodipine | 6 mg/mL | 203340 | 1 | 2021-11-29 |
US Patents and Regulatory Information for NIMODIPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | NIMODIPINE | nimodipine | CAPSULE;ORAL | 076740-001 | Jan 17, 2008 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sun Pharm Inds Inc | NIMODIPINE | nimodipine | CAPSULE;ORAL | 077067-001 | Apr 17, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Heritage Pharms | NIMODIPINE | nimodipine | CAPSULE;ORAL | 077811-001 | May 2, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sofgen Pharms | NIMODIPINE | nimodipine | CAPSULE;ORAL | 201832-001 | Jul 24, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Thepharmanetwork Llc | NIMODIPINE | nimodipine | CAPSULE;ORAL | 090103-001 | Apr 7, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
